Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Ashesh B. Jani*, Gregory C. Ravizzini, Benjamin A. Gartrell, Barry A. Siegel, Przemyslaw Twardowski, Daniel Saltzstein, Mark T. Fleming, Albert Chau, Phillip Davis, Brian F. Chapin, David M. Schuster, Mohamad Allaf, Ryan J. Avery, Norbert Avril, Helen Barker, Laurence Belkoff, Peter Bostrom, Michael L. Cher, Diane Chisholm, Matthew F. CovingtonIan Cox, Giuseppe Esposito, Peter Gardiner, David Gauden, Brian Helfand, Rick Hermsen, David Josephson, Matthew Kay, Bridget F. Koontz, Lale Kostakoglu, Phillip Kuo, William Lavely, Ing Han Liem, Mary Lokuta, Benjamin Lowentritt, Jeff Michalski, Matthew P. Miller, Karen Mourtzikos, Russell Pachynski, Ross Penny, Morand Piert, Andrei Purysko, Soroush Rais-Bahrami, Bital Savir-Baruch, Rik Somford, Ashutosh Tewari, Edward Uchio, Don Yoo, Katherine Zukotynski
Dive into the research topics of 'Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)'. Together they form a unique fingerprint.